Literature DB >> 21949239

Myotonic dystrophy protein kinase is critical for nuclear envelope integrity.

Erin B Harmon1, Michelle L Harmon, Tricia D Larsen, Jie Yang, Joseph W Glasford, M Benjamin Perryman.   

Abstract

Myotonic dystrophy 1 (DM1) is a multisystemic disease caused by a triplet nucleotide repeat expansion in the 3' untranslated region of the gene coding for myotonic dystrophy protein kinase (DMPK). DMPK is a nuclear envelope (NE) protein that promotes myogenic gene expression in skeletal myoblasts. Muscular dystrophy research has revealed the NE to be a key determinant of nuclear structure, gene regulation, and muscle function. To investigate the role of DMPK in NE stability, we analyzed DMPK expression in epithelial and myoblast cells. We found that DMPK localizes to the NE and coimmunoprecipitates with Lamin-A/C. Overexpression of DMPK in HeLa cells or C2C12 myoblasts disrupts Lamin-A/C and Lamin-B1 localization and causes nuclear fragmentation. Depletion of DMPK also disrupts NE lamina, showing that DMPK is required for NE stability. Our data demonstrate for the first time that DMPK is a critical component of the NE. These novel findings suggest that reduced DMPK may contribute to NE instability, a common mechanism of skeletal muscle wasting in muscular dystrophies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21949239      PMCID: PMC3220565          DOI: 10.1074/jbc.M111.241455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

Review 1.  The nuclear envelope and human disease.

Authors:  Antoine Muchir; Howard J Worman
Journal:  Physiology (Bethesda)       Date:  2004-10

2.  The nuclear lamin protein family in higher vertebrates. Identification of quantitatively minor lamin proteins by monoclonal antibodies.

Authors:  C F Lehner; V Kurer; H M Eppenberger; E A Nigg
Journal:  J Biol Chem       Date:  1986-10-05       Impact factor: 5.157

3.  Myotonic dystrophy protein kinase domains mediate localization, oligomerization, novel catalytic activity, and autoinhibition.

Authors:  E W Bush; S M Helmke; R A Birnbaum; M B Perryman
Journal:  Biochemistry       Date:  2000-07-25       Impact factor: 3.162

4.  Emerin binding to Btf, a death-promoting transcriptional repressor, is disrupted by a missense mutation that causes Emery-Dreifuss muscular dystrophy.

Authors:  Tokuko Haraguchi; James M Holaska; Miho Yamane; Takako Koujin; Noriyo Hashiguchi; Chie Mori; Katherine L Wilson; Yasushi Hiraoka
Journal:  Eur J Biochem       Date:  2004-03

5.  Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis.

Authors:  Nikolai A Timchenko; Roma Patel; Polina Iakova; Zong-Jin Cai; Ling Quan; Lubov T Timchenko
Journal:  J Biol Chem       Date:  2004-01-13       Impact factor: 5.157

6.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction.

Authors:  Jan Lammerding; P Christian Schulze; Tomosaburo Takahashi; Serguei Kozlov; Teresa Sullivan; Roger D Kamm; Colin L Stewart; Richard T Lee
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  Overexpression of human myotonic dystrophy protein kinase in Schizosaccharomyces pombe induces an abnormal polarized and swollen cell morphology.

Authors:  Noboru Sasagawa; Yoshihiro Kino; Yuya Takeshita; Yoko Oma; Shoichi Ishiura
Journal:  J Biochem       Date:  2003-10       Impact factor: 3.387

8.  Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.

Authors:  Jos L V Broers; Emiel A G Peeters; Helma J H Kuijpers; Jorike Endert; Carlijn V C Bouten; Cees W J Oomens; Frank P T Baaijens; Frans C S Ramaekers
Journal:  Hum Mol Genet       Date:  2004-09-14       Impact factor: 6.150

9.  Myotonic dystrophy protein kinase is expressed in embryonic myocytes and is required for myotube formation.

Authors:  Erin B Harmon; Michelle L Harmon; Tricia D Larsen; Alicia F Paulson; M Benjamin Perryman
Journal:  Dev Dyn       Date:  2008-09       Impact factor: 3.780

10.  Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy.

Authors:  T Sullivan; D Escalante-Alcalde; H Bhatt; M Anver; N Bhat; K Nagashima; C L Stewart; B Burke
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  10 in total

Review 1.  Mendelian forms of structural cardiovascular disease.

Authors:  Calum A MacRae
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

2.  Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts.

Authors:  R Rodríguez; O Hernández-Hernández; J J Magaña; R González-Ramírez; E S García-López; B Cisneros
Journal:  Mol Biol Rep       Date:  2014-10-12       Impact factor: 2.316

3.  Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.

Authors:  Alessandra Perfetti; Simona Greco; Pasquale Fasanaro; Enrico Bugiardini; Rosanna Cardani; Jose M Garcia-Manteiga; Jose M Garcia Manteiga; Michela Riba; Davide Cittaro; Elia Stupka; Giovanni Meola; Fabio Martelli
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

4.  Epigenetics of the myotonic dystrophy-associated DMPK gene neighborhood.

Authors:  Lauren Buckley; Michelle Lacey; Melanie Ehrlich
Journal:  Epigenomics       Date:  2016-01-12       Impact factor: 4.778

5.  Toward a more personalized motor function rehabilitation in Myotonic dystrophy type 1: The role of neuroplasticity.

Authors:  Simona Portaro; Antonino Naro; Antonino Chillura; Luana Billeri; Alessia Bramanti; Placido Bramanti; Carmelo Rodolico; Rocco Salvatore Calabrò
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

6.  Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1.

Authors:  Stefan Hintze; Lisa Knaier; Sarah Limmer; Benedikt Schoser; Peter Meinke
Journal:  Front Physiol       Date:  2018-10-30       Impact factor: 4.566

7.  RNA-sequencing reveals altered skeletal muscle contraction, E3 ligases, autophagy, apoptosis, and chaperone expression in patients with critical illness myopathy.

Authors:  Monica Llano-Diez; Wen Fury; Haruka Okamoto; Yu Bai; Jesper Gromada; Lars Larsson
Journal:  Skelet Muscle       Date:  2019-04-16       Impact factor: 4.912

Review 8.  Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.

Authors:  Tiago Mateus; Filipa Martins; Alexandra Nunes; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

9.  Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts.

Authors:  Diana Viegas; Cátia D Pereira; Filipa Martins; Tiago Mateus; Odete A B da Cruz E Silva; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 10.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.